China Vanke wins support of top shareholder, which plans billion-dollar investment
By P.R. Venkat
China Vanke's (HK:2202) majority shareholder has expressed its support of the property developer, including making a commitment to spend more than $1.0 billion on its projects.
State-owned Shenzhen Metro Group said at a recent meeting with financial institutions that it is optimistic about Vanke's prospects and has never planned or expressed intentions to reduce its stake, Vanke said late Monday.
Shenzhen Metro owns over 30% of Vanke, according to FactSet.
As part of demonstrating confidence in Vanke, Shenzhen Metro will buy some of the developer's urban renewal projects in Shenzhen, China, for more than 10 billion yuan ($1.38 billion), which will help boost liquidity, the developer said.
Vanke, like may of its peers, has been hit by declining property sales and weak consumer confidence. Some of China's property companies face a severe liquidity crisis, leading to defaults by developers including debt-laden China Evergrande Group and Sunac China.
The slumping property market has also become a significant drag on China's economic recovery, with authorities and policymakers introducing a number of stimulus measures to prop up buyer demand.
Vanke also said Shenzhen Metro is actively preparing to purchase the company's bonds in the open market.
"In our view, Vanke has enough liquidity to meet its debt maturities, both onshore and offshore, for the rest of 2023 and 2024," S&P Global Ratings said in a note last week, citing the company's improving property sales.
The ratings agency expects Vanke to see positive operating cash flows in the next 12-18 months if it maintains monthly sales at current levels.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-06-23 2108ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth